Investment Analysts’ Updated EPS Estimates for September 19th (AAPL, ACRS, ACSO, ADCT, BC, BEG, BL, BSX, CCR, CFG)

Investment Analysts’ updated eps estimates for Tuesday, September 19th:

Apple (NASDAQ:AAPL) had its equal weight rating reiterated by analysts at Barclays PLC. The firm currently has a $167.00 price target on the stock.

Apple (NASDAQ:AAPL) had its outperform rating reaffirmed by analysts at Evercore ISI. Evercore ISI currently has a $210.00 target price on the stock.

Aclaris Therapeutics (NASDAQ:ACRS) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $38.00 price target on the stock.

Aclaris Therapeutics (NASDAQ:ACRS) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $43.00 price target on the stock.

accesso Technology Group (LON:ACSO) had its buy rating reiterated by analysts at Shore Capital.

ADC Therapeutics (NYSE:ADCT) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $12.00 target price on the stock.

Brunswick (NYSE:BC) had its buy rating reiterated by analysts at Roth Mkm. They currently have a $91.00 target price on the stock.

Brunswick (NYSE:BC) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $100.00 target price on the stock.

Begbies Traynor Group (LON:BEG) had its house stock rating reissued by analysts at Shore Capital.

BlackLine (NASDAQ:BL) had its hold rating reaffirmed by analysts at Truist Financial Co.. They currently have a $60.00 price target on the stock.

Boston Scientific (NYSE:BSX) had its outperform rating reissued by analysts at Evercore ISI. The firm currently has a $60.00 price target on the stock.

C&C Group (LON:CCR) had its buy rating reaffirmed by analysts at Shore Capital.

Citizens Financial Group (NYSE:CFG) had its neutral rating reaffirmed by analysts at Citigroup Inc.. Citigroup Inc. currently has a $33.00 price target on the stock.

C.H. Robinson Worldwide (NASDAQ:CHRW) had its hold rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $91.00 price target on the stock.

Clarus (NASDAQ:CLAR) had its buy rating reissued by analysts at Roth Mkm. They currently have a $9.50 price target on the stock.

Comerica (NYSE:CMA) had its buy rating reissued by analysts at Citigroup Inc.. They currently have a $58.00 target price on the stock.

Cinemark (NYSE:CNK) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $21.00 price target on the stock.

Cogent Biosciences (NASDAQ:COGT) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $22.00 price target on the stock.

Crocs (NASDAQ:CROX) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $133.00 target price on the stock.

Coterra Energy (NYSE:CTRA) had its buy rating reiterated by analysts at Mizuho. The firm currently has a $42.00 price target on the stock.

Walt Disney (NYSE:DIS) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $105.00 target price on the stock.

Masonite International (NYSE:DOOR) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $125.00 price target on the stock.

Darden Restaurants (NYSE:DRI) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $183.00 target price on the stock.

Precision BioSciences (NASDAQ:DTIL) had its buy rating reissued by analysts at HC Wainwright. They currently have a $3.00 price target on the stock.

Elutia (NASDAQ:ELUT) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $8.00 target price on the stock.

Enanta Pharmaceuticals (NASDAQ:ENTA) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $48.00 price target on the stock.

EQT (NYSE:EQT) had its hold rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $39.00 target price on the stock.

Etsy (NASDAQ:ETSY) had its buy rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $126.00 price target on the stock.

Etsy (NASDAQ:ETSY) had its outperform rating reaffirmed by analysts at Evercore ISI. Evercore ISI currently has a $105.00 target price on the stock.

Five9 (NASDAQ:FIVN) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a $90.00 price target on the stock.

First Wave BioPharma (NASDAQ:FWBI) had its buy rating reaffirmed by analysts at Roth Mkm.

General Dynamics (NYSE:GD) had its buy rating reissued by analysts at Citigroup Inc.. Citigroup Inc. currently has a $283.00 price target on the stock.

Globant (NYSE:GLOB) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $250.00 price target on the stock.

Green Plains (NASDAQ:GPRE) had its buy rating reaffirmed by analysts at Truist Financial Co.. They currently have a $45.00 price target on the stock.

HashiCorp (NASDAQ:HCP) had its neutral rating reaffirmed by analysts at Citigroup Inc.. They currently have a $28.00 price target on the stock.

Harmony Biosciences (NASDAQ:HRMY) had its buy rating reaffirmed by analysts at Mizuho. They currently have a $54.00 price target on the stock.

Hancock Whitney (NASDAQ:HWC) had its buy rating reiterated by analysts at Truist Financial Co.. They currently have a $47.00 target price on the stock.

InterContinental Hotels Group (LON:IHG) had its buy rating reissued by analysts at Bank of America Co.. The firm currently has a GBX 7,200 ($89.19) target price on the stock.

indie Semiconductor (NASDAQ:INDI) had its buy rating reaffirmed by analysts at Roth Mkm. The firm currently has a $15.00 price target on the stock.

indie Semiconductor (NASDAQ:INDI) had its buy rating reaffirmed by analysts at Benchmark Co.. They currently have a $17.00 price target on the stock.

Insmed (NASDAQ:INSM) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $46.00 target price on the stock.

Intuit (NASDAQ:INTU) had its buy rating reiterated by analysts at Mizuho. Mizuho currently has a $600.00 target price on the stock.

Invitation Homes (NYSE:INVH) had its in-line rating reaffirmed by analysts at Evercore ISI. The firm currently has a $38.00 target price on the stock.

CarMax (NYSE:KMX) had its neutral rating reissued by analysts at Wedbush. They currently have a $85.00 target price on the stock.

Lucid Group (NASDAQ:LCID) had its sector perform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $6.00 target price on the stock.

Lennar (NYSE:LEN) had its buy rating reiterated by analysts at Citigroup Inc.. They currently have a $139.00 target price on the stock.

Ligand Pharmaceuticals (NASDAQ:LGND) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $144.00 target price on the stock.

LanzaTech Global (NASDAQ:LNZA) had its buy rating reaffirmed by analysts at Roth Mkm. They currently have a $8.00 target price on the stock.

LightPath Technologies (NASDAQ:LPTH) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $3.00 target price on the stock.

Madrigal Pharmaceuticals (NASDAQ:MDGL) had its outperform rating reissued by analysts at Evercore ISI. They currently have a $325.00 price target on the stock.

Montrose Environmental Group (NYSE:MEG) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $54.00 price target on the stock.

Modular Medical (NASDAQ:MODD) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. They currently have a $3.50 target price on the stock.

Mercury Systems (NASDAQ:MRCY) had its buy rating reissued by analysts at Truist Financial Co.. They currently have a $48.00 price target on the stock.

NanoString Technologies (NASDAQ:NSTG) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a $10.00 price target on the stock.

Omnicom Group (NYSE:OMC) had its buy rating reissued by analysts at Citigroup Inc.. They currently have a $113.00 price target on the stock.

Oracle (NYSE:ORCL) had its buy rating reaffirmed by analysts at Mizuho. The firm currently has a $150.00 target price on the stock.

Penumbra (NYSE:PEN) had its overweight rating reiterated by analysts at Piper Sandler. They currently have a $335.00 price target on the stock.

Progress Software (NASDAQ:PRGS) had its outperform rating reiterated by analysts at Wedbush. They currently have a $65.00 target price on the stock.

QuidelOrtho (NASDAQ:QDEL) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $140.00 target price on the stock.

Regulus Therapeutics (NASDAQ:RGLS) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $9.00 price target on the stock.

Rocket Lab USA (NASDAQ:RKLB) had its buy rating reaffirmed by analysts at Roth Mkm. The firm currently has a $10.00 target price on the stock.

Rambus (NASDAQ:RMBS) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $73.00 target price on the stock.

JMP Securities began coverage on shares of Ryan Specialty (NYSE:RYAN). JMP Securities issued a market perform rating on the stock.

Rezolute (NASDAQ:RZLT) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $5.00 price target on the stock.

Steven Madden (NASDAQ:SHOO) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $40.00 target price on the stock.

SPS Commerce (NASDAQ:SPSC) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $205.00 target price on the stock.

Block (NYSE:SQ) had its neutral rating reissued by analysts at Wedbush. They currently have a $70.00 target price on the stock.

Stagwell (NASDAQ:STGW) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $9.00 target price on the stock.

Stagwell (NASDAQ:STGW) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $9.00 target price on the stock.

Strategic Education (NASDAQ:STRA) had its hold rating reissued by analysts at Truist Financial Co.. They currently have a $85.00 target price on the stock.

Synaptics (NASDAQ:SYNA) had its buy rating reissued by analysts at Mizuho. Mizuho currently has a $115.00 target price on the stock.

Atlassian (NASDAQ:TEAM) had its buy rating reissued by analysts at Mizuho. They currently have a $240.00 target price on the stock.

Team17 Group (LON:TM17) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 650 ($8.05) price target on the stock.

Team17 Group (LON:TM17) had its buy rating reissued by analysts at Shore Capital.

Trustpilot Group (LON:TRST) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 160 ($1.98) price target on the stock.

Travere Therapeutics (NASDAQ:TVTX) had its outperform rating reissued by analysts at Evercore ISI. They currently have a $30.00 target price on the stock.

10x Genomics (NASDAQ:TXG) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $70.00 price target on the stock.